SciELO - Scientific Electronic Library Online

 
vol.70 issue9Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experienceIdiopathic Parkinson's disease: vocal and quality of life analysis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Abstract

UTIUMI, Marco A. T. et al. Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of Scans Without Evidence of Dopaminergic Deficit (SWEDDs). Arq. Neuro-Psiquiatr. [online]. 2012, vol.70, n.9, pp. 667-673. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X2012000900004.

The clinical diagnosis of Parkinson's disease (PD) is susceptible to misdiagnosis, especially in the earlier stages of the disease. Recently, in vivo imaging techniques assessing the presynaptic dopamine transporter (DAT) have emerged as a useful tool in PD diagnosis, improving its accuracy. OBJECTIVE: It was to illustrate the clinical usefulness of a brain single-photon emission computed tomography (SPECT) DAT ligand, and highlight relevant aspects of scans without evidence of dopaminergic deficit (SWEDDs) in this context. CASES: We described four representative patients with clinically unclear parkinsonian syndromes who underwent [99mTc]-TRODAT-1 SPECT and reviewed the clinical implications. CONCLUSION: DAT-SPECT is an important, cost-effective, technique for the differential diagnosis of parkinsonian syndromes. Additionally, SWEDD cases present clinical and paraclinical peculiarities that may retrospectively identify them as essential/dystonic tremor. The lack of histopathological data limits further conclusions.

Keywords : Parkinson disease; scans without evidence of dopaminergic deficit; tomography; emission-computed; single-photon; Tc-99mtrodat- 1; dopamine transporter.

        · abstract in Portuguese     · text in English     · pdf in English